First Time Loading...

Prescient Therapeutics Ltd
ASX:PTX

Watchlist Manager
Prescient Therapeutics Ltd Logo
Prescient Therapeutics Ltd
ASX:PTX
Watchlist
Price: 0.048 AUD -4% Market Closed
Updated: May 2, 2024

Prescient Therapeutics Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Prescient Therapeutics Ltd
Cash from Financing Activities Peer Comparison

Comparables:
IMM
MSB
CSL
CUV
TLX

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Prescient Therapeutics Ltd
ASX:PTX
Cash from Financing Activities
-AU$10.7m
CAGR 3-Years
N/A
CAGR 5-Years
-189%
CAGR 10-Years
N/A
Immutep Ltd
ASX:IMM
Cash from Financing Activities
AU$76m
CAGR 3-Years
15%
CAGR 5-Years
29%
CAGR 10-Years
19%
Mesoblast Ltd
ASX:MSB
Cash from Financing Activities
$67.8m
CAGR 3-Years
-11%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
CSL Ltd
ASX:CSL
Cash from Financing Activities
-$1.6B
CAGR 3-Years
-39%
CAGR 5-Years
-25%
CAGR 10-Years
-8%
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Cash from Financing Activities
-AU$2.7m
CAGR 3-Years
-22%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Telix Pharmaceuticals Ltd
ASX:TLX
Cash from Financing Activities
AU$10.2m
CAGR 3-Years
-33%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Prescient Therapeutics Ltd's Cash from Financing Activities?
Cash from Financing Activities
-10.7m AUD

Based on the financial report for Dec 31, 2023, Prescient Therapeutics Ltd's Cash from Financing Activities amounts to -10.7m AUD.

What is Prescient Therapeutics Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-189%